FDA Import Refusal SCS-6319475-1/21/1 — SHRI GUJARAT MAHILA LOKSWASTHYASEW
The FDA refused shipment SCS-6319475-1/21/1 from SHRI GUJARAT MAHILA LOKSWASTHYASEW (India) on Oct 28, 2024. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280,75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Oct 28, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VBY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3280,75